What is Biofire Technologies?
Biofire Technologies operates at the intersection of high-stakes engineering and consumer safety. The company is composed of a multidisciplinary team of experts with backgrounds in aerospace, medical device manufacturing, and autonomous systems. Their core competency lies in the development of biometric-enabled firearms designed to enhance safety and prevent unauthorized access. By applying rigorous engineering standards—typically reserved for satellite and supersonic jet development—to the home defense market, Biofire is carving out a unique niche. Their market position is defined by a commitment to innovation, aiming to modernize traditional firearm mechanics through the integration of advanced authentication technology, thereby addressing critical safety concerns for families and responsible gun owners.
How much funding has Biofire Technologies raised?
Biofire Technologies has raised a total of $31M across 2 funding rounds:
Angel/Seed
$17M
Series A
$14M
Angel/Seed (2022): $17M with participation from Ron Conway and Gavin de Becker
Series A (2022): $14M led by Founders Fund
Key Investors in Biofire Technologies
Founders Fund
A prominent venture capital firm known for backing transformative companies across various sectors, with a history of supporting high-impact founders in technology and aerospace.
Ron Conway
A legendary angel investor and philanthropist who has provided early-stage capital to some of the most influential technology companies in Silicon Valley.
Gavin de Becker
A leading expert in security and threat assessment, providing strategic insight and capital to ventures focused on safety and protective technologies.
What's next for Biofire Technologies?
With the successful closure of its latest financing round, Biofire Technologies is poised to transition from the research and development phase into full-scale commercialization. The strategic focus will likely center on refining its biometric authentication systems to ensure reliability under diverse environmental conditions, while simultaneously navigating the complex regulatory landscape inherent to the firearms industry. As the company scales, it will need to balance rapid technological iteration with the stringent quality control measures required for safety-critical hardware. Future growth will depend on the successful market adoption of its flagship products and the ability to maintain a competitive edge through continuous intellectual property development and strategic partnerships within the defense and security sectors.
See full Biofire Technologies company page
